Inflect Health

Type

Accelerator/Incubator

Status

Active

Location

Emeryville, United States

Total investments

13

Average round size

7M

Portfolio companies

11

Follow on index

0.15

Areas of investment
InternetSoftwareArtificial IntelligenceMachine LearningHealth CareAppsEducationMedical DeviceMedicalVideo

Investor highlights

Industry focus
Healthcare
Stage focus
Seed

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
13
Lead investments
0
Follow on index
0.15
Investments by industry
  • Health Care (9)
  • Education (4)
  • Medical (3)
  • Machine Learning (3)
  • Artificial Intelligence (3)
  • Show 16 more
Investments by region
  • United States (13)
Peak activity year
2022

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
4
Group Appearance index
0.85

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Biocogniv 31 Aug 2020 Artificial Intelligence, Machine Learning, Health Care, Medical Device Seed 6M United States, Vermont
Macro Trials 21 Jun 2023 Health Care, Life Science, Biopharma, Clinical Trials Seed 6M United States, California, Los Angeles
ScanlanKemperBard 15 May 2019 Real Estate, Banking, Real Estate Investment Seed 350K United States, Oregon, Portland
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.